ArticleACS nano2024

Correction to "Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity".

Xiang Ling et al.PubMed ↗Publisher ↗

No numbers read from the abstract.